← Back to Search

mHealth Application for Colorectal Cancer Screening (SUCCEED Trial)

N/A
Recruiting
Led By Maria Thomson, Ph.D.
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult men
Eligible for colorectal cancer (CRC) screening at time of study enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

SUCCEED Trial Summary

This trial studies how to increase colorectal cancer screening among African American men by involving barbers as Community Champions.

Who is the study for?
This trial is for adult men who identify as Black or African American, are due for colorectal cancer screening, and live or work in Petersburg, VA or nearby counties. It's not open to those who can't speak/read English or are already up-to-date with their screenings.Check my eligibility
What is being tested?
The study is testing a mobile health application designed to understand the needs and attitudes of Black men towards colorectal cancer screening and how community leaders like barbers can encourage screening participation.See study design
What are the potential side effects?
Since this trial involves an mHealth Application rather than a drug, traditional side effects aren't expected. However, participants may experience discomfort discussing personal health issues.

SUCCEED Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an adult man.
Select...
I am due for a colorectal cancer screening.

SUCCEED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Colorectal Screening Status
Secondary outcome measures
Determine feasibility of Mobile Health (mHealth) Application -Enrollment
Determine the feasibility of the mHealth Application - Sharing Content
Determine the feasibility of the mHealth Application- Clinic/ Screening Request
+2 more

SUCCEED Trial Design

1Treatment groups
Experimental Treatment
Group I: Tailored Screen to Save (S2S) contentExperimental Treatment1 Intervention
Content to be delivered using a combination of short video and text-based information optimized for delivery via Quick Response (QR) codes for smartphones.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
mHealth Application
2021
N/A
~160

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
697 Previous Clinical Trials
22,885,074 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,095 Total Patients Enrolled
Maria Thomson, Ph.D.Principal InvestigatorVirginia Commonwealt University

Media Library

Tailored Screen to Save (S2S) content Clinical Trial Eligibility Overview. Trial Name: NCT05980182 — N/A
Colorectal Cancer Research Study Groups: Tailored Screen to Save (S2S) content
Colorectal Cancer Clinical Trial 2023: Tailored Screen to Save (S2S) content Highlights & Side Effects. Trial Name: NCT05980182 — N/A
Tailored Screen to Save (S2S) content 2023 Treatment Timeline for Medical Study. Trial Name: NCT05980182 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has recruitment for this experiment commenced?

"According to the clinicaltrials.gov, this study has completed recruitment and is no longer seeking participants. The trial was initially posted on August 1st 2023 and most recently edited on 8/4/2023. At present there are 1168 other trials recruiting patients across various medical centres."

Answered by AI

Are individuals of a more senior age being recruited for this experiment?

"As delineated in the eligibility criteria, prospective patients must be between 45 and 74 years old to qualify for this study."

Answered by AI

Am I eligible to partake in this medical exploration?

"This trial's inclusion criteria necessitates that all applicants be between 45 and 74 years old, have colorectal cancer, and 30 individuals need to be accepted."

Answered by AI
~13 spots leftby Oct 2024